Dr. Brunner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3333 Burnet Ave
Cincinnati, OH 45229Phone+1 513-636-4676Fax+1 513-636-5568- Is this information wrong?
Summary
- Dr. Hermine Brunner is a pediatric rheumatologist in Cincinnati, OH and is affiliated with Cincinnati Children's Hospital Medical Center. She received her medical degree from Ludwig Maximilian University of Munich Faculty of Medicine and has been in practice 29 years. She also speaks multiple languages, including German. She is experienced in pediatric rheumatology, clinical research, and drug development.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Rheumatology, 1999 - 2001
- University of ChicagoResidency, Pediatrics, 1994 - 1997
- Ludwig Maximilian University of Munich Faculty of MedicineClass of 1989
- Ludwig Maximilian University of Munich Faculty of MedicineClass of 1987
Certifications & Licensure
- OH State Medical License 2000 - 2025
- KY State Medical License 2021 - 2025
- PA State Medical License 2001 - 2002
- IL State Medical License 1994 - 1997
- American Board of Pediatrics Pediatric Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Clinical Trials
- Triptorelin for Ovary Protection in Childhood Onset Lupus Start of enrollment: 2003 Jun 01
- Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus Start of enrollment: 2017 Aug 23
Publications & Presentations
PubMed
- Long-term efficacy and safety of subcutaneous tocilizumab in clinical trials of polyarticular or systemic juvenile idiopathic arthritis.Hermine I Brunner, Nicolino Ruperto, Athimalaipet V Ramanan, Gerd Horneff, Kirsten Minden, Inmaculada Calvo Penades, Ekaterina Alexeeva, Gavin Cleary, Sara M Stern, Is...> ;Rheumatology. 2024 Mar 29
- Safety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.Lovell, D., Tzaribachev, N., Henrickson, M., Simonini, G., Griffin, T., Alexeeva, E., Bohnsack, J., Zeft, A., Horneff, G., Vehe, R., Staņēviča, V., Tarvin, S., Trachan...> ;Rheumatology. 2024 Jan 18
- The 4NextGen therapies for SJIA and MAS: part 3 clinical trials in refractory SJIA: historic controls as an alternative to a withdrawal design study.de Benedetti, F., Grom, A., Brunner, H.> ;Pediatric Rheumatology Online Journal. 2024 Jan 3
- Join now to see all
Journal Articles
- Discovery of SERPINA3 as a Candidate Urinary Biomarker of Lupus Nephritis ActivityMichael Bennett, Hermine I Brunner, Prasad Devarajan, Gaurav Gulati, Jessica L Turnier, Sherry Thornton, David Witte, Bruce Aronow, Rheumatology
- Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016Hermine I Brunner, Melissa L Mannion, Judyann C Olson, Vibeke Strand, Daniel J Lovell, Meredith P Riebschleger, Susan Shenoi, Journal of Rheumatology
Lectures
- Tocilizumab Significantly Reduces Flares in Polyarticular Juvenile Idiopathic Arthritis76th Annual Scienific Meeting, Washington, DC, USA
- Tocilizumab Significantly Reduces Flares in Polyarticular Juvenile Idiopathic ArthritisAmerican College of Rheumatology, 76th Annual Scienific Meeting, Washington, DC, USA
Press Mentions
- Bristol Myers Squibb Data at ACR Convergence 2021 Illustrate Scientific Advances for Immune-Mediated Rheumatic DiseasesNovember 3rd, 2021
- Extensive Assessment Critical to Dispel 'Ambiguity' Mimics in Juvenile DermatomyositisAugust 6th, 2021
- FDA Approves Xeljanz for Polyarticular JIAOctober 1st, 2020
- Join now to see all
Grant Support
- Towards Measures Of Lupus Nephritis Activity &Damage For ChildrenNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
- Improved Diagnostics &Advanced Magnetic Resonance Imaging For Pediatric NpsleNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2010–2011
- Improved Diagnostics &Advanced Magnetic Resonance Imaging For Pediatric NpsleNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2008–2009
- Efficacy Measures For Pediatric Lupus StudiesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2007–2009
- Clinical Trial: Triptorelin For Ovary Protection In LupusNational Center For Research Resources2008
- Atherosclerosis Prevention In Pediatric Lupus Erythematosus (APPLE)National Center For Research Resources2006–2007
- Triptorelin For Ovary Protection In LupusNational Center For Research Resources2005–2007
- Long-Term Outcomes In Systemic Lupus ErythematosusNational Center For Research Resources2005–2007
- Triptorelin For Ovary Protection In Childhood LipusFood And Drug Administration2005–2007
- Meaningful Outcome Measures For Pediatrc Lupus TrialsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2006
- Guidelines For Steroids In Children With LupusNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003–2005
- Meaningful Outcome Measures For Pediatric Lupus TrialsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004
- Gonadal Function In Childhood Onset SLENational Center For Research Resources2004
Professional Memberships
- Member
Other Languages
- German
Hospital Affiliations
- Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: